Greenwich LifeSciences, Inc. (GLSI) is a public clinical-stage biopharmaceutical company developing an immunotherapy to prevent breast cancer recurrences.

ID: 1341205336057851904

linkhttps://investor.greenwichlifesciences.com/ calendar_today22-12-2020 02:14:29